Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Will Medicaid Take More Than Its Fair Share Of Dual-Eligible Rebates?

Executive Summary

Industry concerns that states are sometimes obtaining Medicaid drug rebates that are disproportionate to drug expenditures are unlikely to be allayed by CMS' recent proposed rules on Medicaid drug reimbursement

You may also be interested in...

Medicaid AMPs May Include More PBM Discounts, If CMS Can Figure Out How

CMS wants to include a broader array of pharmacy benefit manager price concessions in calculating Medicaid average manufacturer prices for reimbursing outpatient prescription drugs

Rebates To States Should Reflect Proportion Paid By Medicaid – Grassley, BIO

In cases where costs for a physician-administered drug are shared by Medicaid and Medicare, manufacturers should only be required to pay rebates to states for the proportion paid for by Medicaid, Sen. Charles Grassley (R-Iowa) says in an Aug. 14 letter to CMS

NDAs Should Include More Cross-Study Analysis, FDA Says In Draft Guidance

FDA is clarifying that it expects sponsors to provide analysis of efficacy data rather than simply a summary of clinical data as part of the integrated summary of effectiveness in new drug applications




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts